BVXV [NASD]
BiondVax Pharmaceuticals Ltd.
Index- P/E- EPS (ttm)-8.46 Insider Own27.64% Shs Outstand1.43M Perf Week11.42%
Market Cap18.64M Forward P/E- EPS next Y-0.20 Insider Trans0.00% Shs Float1.36M Perf Month18.16%
Income-12.20M PEG- EPS next Q-0.10 Inst Own1.10% Short Float / Ratio2.40% / 3.43 Perf Quarter-3.35%
Sales- P/S- EPS this Y-604.60% Inst Trans-36.72% Short Interest0.03M Perf Half Y-24.30%
Book/sh3.35 P/B2.96 EPS next Y0.00% ROA-45.30% Target Price95.00 Perf Year-38.41%
Cash/sh7.66 P/C1.29 EPS next 5Y- ROE-299.30% 52W Range5.34 - 34.90 Perf YTD-57.80%
Dividend- P/FCF- EPS past 5Y-0.80% ROI- 52W High-71.66% Beta2.43
Dividend %- Quick Ratio5.80 Sales past 5Y- Gross Margin- 52W Low85.38% ATR0.80
Employees15 Current Ratio5.80 Sales Q/Q- Oper. Margin- RSI (14)60.69 Volatility9.87% 10.12%
OptionableNo Debt/Eq4.40 EPS Q/Q-7.10% Profit Margin- Rel Volume0.38 Prev Close9.92
ShortableYes LT Debt/Eq4.35 Earnings- Payout- Avg Volume9.54K Price9.89
Recom- SMA207.38% SMA5023.55% SMA200-14.78% Volume3,279 Change-0.27%
Dec-06-22 08:30AM
07:30AM
Nov-30-22 09:15AM
Nov-29-22 07:00AM
Nov-21-22 06:00AM
08:33AM Loading…
Nov-15-22 08:33AM
Nov-10-22 04:00PM
Nov-03-22 11:30AM
Nov-02-22 04:30PM
Oct-18-22 07:55AM
Oct-11-22 02:00PM
Sep-30-22 07:33AM
Sep-22-22 09:05AM
Sep-20-22 06:15AM
Sep-08-22 09:13AM
07:30AM Loading…
Aug-25-22 07:30AM
Aug-10-22 08:33AM
Jun-27-22 10:22AM
Jun-07-22 08:41AM
Jun-01-22 07:10AM
May-19-22 11:17AM
May-12-22 06:30AM
May-09-22 06:00AM
May-02-22 10:15AM
Apr-05-22 06:49AM
Mar-31-22 04:00PM
Mar-28-22 07:00AM
Mar-24-22 09:45AM
07:05AM
Mar-14-22 08:31AM
08:44AM Loading…
Feb-22-22 08:44AM
Feb-15-22 08:31AM
Feb-10-22 04:30AM
Jan-26-22 07:39AM
Jan-10-22 07:00AM
Jan-03-22 10:15AM
Dec-29-21 04:01PM
Dec-27-21 04:01PM
06:45AM
Dec-23-21 08:01PM
Dec-22-21 11:29AM
09:09AM
09:00AM
07:07AM
Nov-30-21 07:05AM
Nov-24-21 01:46PM
Nov-15-21 05:15AM
Oct-19-21 07:30AM
Sep-15-21 08:59AM
Aug-26-21 04:05PM
Jun-23-21 06:00AM
Jun-15-21 03:23PM
May-13-21 04:54PM
Mar-23-21 07:44AM
Feb-10-21 04:30PM
Feb-03-21 02:45PM
Feb-02-21 04:30PM
Jan-29-21 07:57AM
Jan-28-21 06:48PM
03:23PM
Jan-21-21 07:15AM
Oct-23-20 05:03PM
12:28PM
Oct-02-20 06:00AM
Aug-31-20 06:15AM
Aug-20-20 04:01PM
Aug-13-20 04:01PM
Jul-01-20 06:00AM
Jun-30-20 04:01PM
Jun-16-20 08:57AM
Jun-12-20 08:00AM
Jun-10-20 07:00AM
May-20-20 06:30AM
May-09-20 08:47AM
May-04-20 06:30AM
Mar-24-20 04:01PM
Mar-19-20 07:15AM
Feb-05-20 01:00PM
Jan-16-20 03:05PM
Dec-04-19 08:25AM
Nov-26-19 07:00AM
Nov-18-19 07:15AM
Nov-11-19 08:14AM
Oct-07-19 09:15AM
Aug-28-19 07:45AM
Aug-01-19 10:00AM
Jul-16-19 07:30AM
Jul-08-19 05:45AM
Jun-26-19 10:51AM
Jun-25-19 09:37AM
Jun-18-19 06:30AM
Jun-12-19 03:30PM
Jun-10-19 08:18AM
May-30-19 07:10AM
May-13-19 07:00AM
Apr-30-19 04:01PM
Apr-22-19 08:10AM
Apr-17-19 01:00PM
Apr-15-19 07:50AM
Mar-28-19 07:30AM
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.